Predictors of Intermediate-Term Survival With Destination Locoregional Therapy of Hepatocellular Cancer in Patients Either Ineligible or Unwilling for Liver Transplantation

Journal of Gastrointestinal Oncology - Hong Kong
doi 10.21037/jgo.2017.07.05
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AME Publishing Company

Related search

Favourable Outcome of Pathologic Downstaging by Locoregional Treatment for Hepatocellular Carcinoma in Liver Transplantation

Scientific Reports
Multidisciplinary
2019English

Long-Term Survival in Node-Positive Breast Cancer Treated by Locoregional Therapy Alone

British Journal of Cancer
Cancer ResearchOncology
1998English

Transplant-Related Survival Benefit Should Influence Prioritization for Liver Transplantation Especially in Patients With Hepatocellular Carcinoma

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Locoregional Therapy as a Bridge to Liver Transplantation for Hepatocellular Carcinoma Within Milan Criteria: From a Transplant Oncology Viewpoint

HepatoBiliary Surgery and Nutrition
2018English

Locoregional and Systemic Therapy for Hepatocellular Carcinoma

Journal of Gastrointestinal Oncology
OncologyGastroenterology
2017English

Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival Times

2011English

Living Donor Liver Transplantation for Patients With Hepatocellular Carcinoma in Japan

Hepatoma Research
2018English

Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2020English

Predictors of Long-Term Survival Among High-Grade Serous Ovarian Cancer Patients

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy